The importance of retesting borderline results in COVID-19 diagnostics

Authors

  • Edita M. Grego Department of Molecular Microbiology, IPH Serbia, Belgrade, Serbia
  • Hristina A. Gospodinović Department of Molecular Microbiology, IPH Serbia, Belgrade, Serbia
  • Ljiljana S. Pavlović Center for Microbiology, IPH Serbia, Belgrade, Serbia
  • Verica S. Jovanović Center for Disease Control, IPH Serbia, Belgrade, Serbia

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20221780

Keywords:

COVID-19, Real-time reverse transcription polymerase chain reaction, Ct value

Abstract

The first case of COVID-19 in the Republic of Serbia was registered on 6 March 2020 based on data from the Ministry of Health of the Republic of Serbia.RT-PCR (real-time reverse transcription polymerase chain reaction) is the gold standard for detection for many infective agents. SARS-CoV-2 (human coronavirus 2019) comprises genes coding four basic structural pro­teins (E, M, N and S) and ORF1a and ORF1b genes cod­ing two polyproteins. These genes represent targets for virus detection and the platform for RT-PCR test design.

Metrics

Metrics Loading ...

References

Registrovan prvi oboleli od COVID-19. Available at: https://www.zdravlje.gov.rs/vest/346180/registrovan-prvi-oboleli-od-covid-19.php. Accessed on 25 Feb, 2021.

Van Kasteren P, Van der Veer B,Van den Brink S, Wijsman L, de Jonge J, Van den Brandt A, Molenkamp R, Reusken CBEM, Meijer A Comparison of commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol. 2020;128:104412.

Emam M, Oweda M, Antunes A, El-Hadidi М. Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF 1 ab, S and E genes. Virus Res. 2021;302:198472.

Cho H, Jung YH., Cho HB, Kim HT, Kim KS. Positive control synthesis method for COVID-19 diagnosis by one-step realtime RT-PCR. Clinica Chimica Acta. 2020. 511:149–153. https://doi.org/10.1016/j.cca.2020.10.001

Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing). Available at: https://www.fda.gov/media/137651/ download. Accessed on 25 Feb, 2021.

Xpert®Xpress SARS-CoV-2. Available at: https://www.fda.gov/media/136314/download. Accessed on 25 Feb, 2021.

Downloads

Published

2022-06-28

How to Cite

Grego, E. M., Gospodinović, H. A., S. Pavlović, L., & Jovanović, V. S. (2022). The importance of retesting borderline results in COVID-19 diagnostics. International Journal Of Community Medicine And Public Health, 9(7), 3046–3047. https://doi.org/10.18203/2394-6040.ijcmph20221780

Issue

Section

Letter to the Editor